Reguleren of neutraliseren van anticoagulantia

Strategies to prevent blood loss and reduce transfusion in emergency general surgery, WSES-AAST consensus paper. (opent nieuw venster)

Coccolini F, Shander A, Ceresoli M, Moore E, Tian B, Parini D, Sartelli M, Sakakushev B, Doklestich K, Abu-Zidan F, Horer T, Shelat V, Hardcastle T, Bignami E, Kirkpatrick A, Weber D, Kryvoruchko I, Leppaniemi A, Tan E, Kessel B, Isik A, Cremonini C, Forfori F, Ghiadoni L, Chiarugi M, Ball C, Ottolino P, Hecker A, Mariani D, Melai E, Malbrain M, Agostini V, Podda M, Picetti E, Kluger Y, Rizoli S, Litvin A, Maier R, Beka SG, De Simone B, Bala M, Perez AM, Ordonez C, Bodnaruk Z, Cui Y, Calatayud AP, de Angelis N, Amico F, Pikoulis E, Damaskos D, Coimbra R, Chirica M, Biffl WL, Catena F

Bron‎: World J Emerg Surg 2024;19(1):26.

Geïndexeerd‎: PubMed 39010099

DOI‎: 10.1186/s13017-024-00554-7

https://pubmed.ncbi.nlm.nih.gov/39010099/ (opent nieuw venster)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (opent nieuw venster)

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

Bron‎: Lancet 2015;385(9982):2077-87.

Geïndexeerd‎: PubMed 25728933

DOI‎: 10.1016/S0140-6736(14)61685-8

https://www.ncbi.nlm.nih.gov/pubmed/25728933 (opent nieuw venster)

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (opent nieuw venster)

Kaatz S, Kouides PA, Garcia DA, Spyropolous AC, Crowther M, Douketis JD, Chan AK, James A, Moll S, Ortel TL, Van Cott EM, Ansell J.

Bron‎: Am J Hematol 2012;87 Suppl 1:S141-5.

Geïndexeerd‎: PubMed 22473649

DOI‎: 10.1002/ajh.23202

https://www.ncbi.nlm.nih.gov/pubmed/22473649 (opent nieuw venster)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (opent nieuw venster)

Levi M, Eerenberg E, Kamphuisen PW.

Bron‎: J Thromb Haemost 2011;9(9):1705-12.

Geïndexeerd‎: PubMed 21729240

DOI‎: 10.1111/j.1538-7836.2011.04432.x

https://www.ncbi.nlm.nih.gov/pubmed/21729240 (opent nieuw venster)

Emergency reversal of warfarin anticoagulation. (opent nieuw venster)

Lin Y, Callum J.

Bron‎: CMAJ 2010;182(18):2004.

Geïndexeerd‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (opent nieuw venster)

Management of anticoagulation agents in trauma patients. (opent nieuw venster)

McCoy CC, Lawson JH, Shapiro ML.

Bron‎: Clin Lab Med 2014;34(3):563-74.

Geïndexeerd‎: PubMed 25168942

DOI‎: 10.1016/j.cll.2014.06.013

https://www.ncbi.nlm.nih.gov/pubmed/25168942 (opent nieuw venster)

Idarucizumab for dabigatran reversal - full cohort analysis. (opent nieuw venster)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Bron‎: N Engl J Med 2017;377(5):431-41.

Geïndexeerd‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (opent nieuw venster)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (opent nieuw venster)

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME.

Bron‎: Anesth Analg 2011;113(4):703-10.

Geïndexeerd‎: PubMed 21890888

DOI‎: 10.1213/ANE.0b013e318228c690

https://www.ncbi.nlm.nih.gov/pubmed/21890888 (opent nieuw venster)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (opent nieuw venster)

Woo CH, Patel N, Conell C, Rao VA, Faigeles BS, Patel MC, Pombra J, Akins PT, Axelrod YK, Ge IY, Sheridan WF, Flint AC.

Bron‎: World Neurosurg 2014;81(1):110-5.

Geïndexeerd‎: PubMed 23220122

DOI‎: 10.1016/j.wneu.2012.12.002

https://www.ncbi.nlm.nih.gov/pubmed/23220122 (opent nieuw venster)

TRAUMA EN SPOEDEISENDE HULP

Reguleren of neutraliseren van anticoagulantia

Nederlands

Reguleren of neutraliseren van anticoagulantia

https://assetsnffrgf-a.akamaihd.net/assets/ct/e8b2bff3b7/images/syn_placeholder_sqr.png

Reguleren of neutraliseren van anticoagulantia

Strategies to prevent blood loss and reduce transfusion in emergency general surgery, WSES-AAST consensus paper. (opent nieuw venster)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (opent nieuw venster)

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (opent nieuw venster)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (opent nieuw venster)

Emergency reversal of warfarin anticoagulation. (opent nieuw venster)

Management of anticoagulation agents in trauma patients. (opent nieuw venster)

Idarucizumab for dabigatran reversal - full cohort analysis. (opent nieuw venster)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (opent nieuw venster)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (opent nieuw venster)

Ziekenhuiscontactcomité (zcc)

Medische informatiepakketten

Video’s

Reguleren of neutraliseren van anticoagulantia

Selecteer een taal

Delen